中文名稱2,4(1H,3H)-Pyrimidinedione,1-(6-bromo-5-fluoro-1-methyl-1H-indazol-3-yl)dihydro-中文同義詞英文名稱2,4(1H,3H)-Pyrimidinedione,1-(6-bromo-5-fluoro-1-methyl-1H-indazol-3-yl)dihydro-英文同義詞2,4(1H,3H)-Pyrimidinedione,1-(6-bromo-5-fluoro-1-methyl-1H-indazol-3-yl)dihydro-CAS號(hào)2760850-50-6分子式C12H10BrFN4O2分子量341.14
中文名稱2,4(1H,3H)-Pyrimidinedione,1-(6-bromo-5-fluoro-1-methyl-1H-indazol-3-yl)dihydro-中文同義詞英文名稱2,4(1H,3H)-Pyrimidinedione,1-(6-bromo-5-fluoro-1-methyl-Chemicalbook1H-indazol-3-yl)dihydro-英文同義詞2,4(1H,3H)-Pyrimidinedione,1-(6-bromo-5-fluoro-1-methyl-1H-indazol-3-yl)dihydro-CAS號(hào)2760850-50-6分子式C12H10BrFN4O2分子量341.14
關(guān)鍵字： 2760850-50-6;2,4(1H,3H)-Pyrimidin;
薈聚醫(yī)藥科技有限公司，2021年10月成立，經(jīng)營(yíng)范圍包括：分子砌塊、醫(yī)藥中間體、訂制合成、原料藥研發(fā)、技術(shù)轉(zhuǎn)讓等。